Dr Lisa McNally

I am a pharmaceutical physician with 25 years in clinical research including 19 in pharma and biotech. I have led both safety and clinical development and been a CMO. I bring deep expertise in benefit risk due diligence for M&A, strategy, and risk management, specifically within the biotech sector. I have specific expertise in novel therapeutics including antibodies, cell therapy, and genomic therapeutics.

My background spans high-stakes leadership and crisis management, due diligence, global compliance and regulatory strategy, making me an asset to companies planning on filing for marketing authorisations, navigating acquisitions, scaling operations, or managing complex risk landscapes. I’ve worked extensively with biotech executives, regulators, and investors to assess and mitigate risks while ensuring long-term growth.

Companies preparing for M&A, market entry, or major regulatory milestones would benefit most from my experience in guiding strategic decisions and safeguarding value.